MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

28 Oct 2021 Evaluate
An increase of about 175.63% to Rs. 841.50 millions in the total revenue was observed for the quarter ended September 2021. The total revenue was pegged at Rs. 305.30 millions during the similar quarter previous year.The Net Loss for the quarter ended September 2021 is Rs. -28.10 millions as compared to Net Loss of Rs. -182.50 millions of corresponding quarter ended September 2020Operating profit surged to 421.50 millions from the corresponding previous quarter of 121.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 841.50 305.30 175.63 1480.60 603.30 145.42 2080.10 5807.40 -64.18
Other Income 172.30 335.80 -48.69 355.20 414.60 -14.33 661.50 695.50 -4.89
PBIDT 421.50 121.40 247.20 644.90 -101.10 -737.88 86.90 2431.30 -96.43
Interest 84.60 89.80 -5.79 162.50 157.40 3.24 341.70 470.20 -27.33
PBDT 311.90 31.60 887.03 457.40 -258.50 -276.94 -254.80 1961.10 -112.99
Depreciation 357.40 361.90 -1.24 710.80 717.80 -0.98 1432.10 1406.50 1.82
PBT -45.50 -330.30 -86.22 -253.40 -976.30 -74.04 -1686.90 554.60 -404.17
TAX -17.40 -147.80 -88.23 -85.70 -341.40 -74.90 641.20 169.40 278.51
Deferred Tax -17.40 -147.80 -88.23 -85.70 -341.40 -74.90 461.50 76.40 504.06
PAT -28.10 -182.50 -84.60 -167.70 -634.90 -73.59 -2328.10 385.20 -704.39
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.80 -0.06
PBIDTM(%) 50.09 39.76 25.97 43.56 -16.76 -359.92 4.18 41.87 -90.02
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..